Diagnostic and Device Development
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
192
NCT05188729
Open-Label Proof of Concept Study of VP-315 in Basal Cell Carcinoma
Phase: Phase 2
Role: Collaborator
Start: Feb 1, 2022
Completion: Apr 15, 2024
NCT06718322
PIECES - Towards Large-Scale Adaptation and Tailored Implementation of Primary Cancer Prevention Programs
Phase: N/A
Start: Dec 1, 2024
Completion: Dec 31, 2026
Loading map...